openPR Logo
Press release

Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Pancreatic Cancer

10-19-2020 06:34 AM CET | Health & Medicine

Press release from: The Insight Partners

Pancreatic Cancer Therapy Market to 2025

Pancreatic Cancer Therapy Market to 2025

Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of death related to cancer in the US and is expected to be the second leading cause of death by 2020. According to Cancer Research UK, approximately 9,921 new cases of pancreatic cancer were diagnosed in the UK in 2015, while 8,912 patients died due to same cancer. The cancer is almost always fatal and thus demands potential therapies for the patients’ treatment. For instance, the American Cancer Society suggests that pancreatic cancer accounts for approximately 3% of deaths of all cancers in the US. According to the National Institute of Health, an estimated of 68,615 patients in 2015 were living with pancreatic cancer in the US.

Download sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPMD00002009/?openpr-10144

The pancreatic cancer therapy market is expected to reach US$ 4056.4 million by 2025 from US$ 2011.2 million in 2017; it is estimated to grow at a CAGR of 8.1% from 2018 to 2025.

Company Profiles

Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Amgen Inc
Novartis AG
Celgene Corporation
Merck & Co., Inc
Pharmacyte Biotech Inc
Clovis Oncology
Teva Pharmaceutical Industries Ltd
Pfizer Inc

Pancreatic cancer begins when the cells in the pancreas grow uncontrollably. Based on the type of cell affected, pancreatic cancer can be classified into two types, exocrine tumors, and endocrine tumors. These tumors behave differently. Hence they are treated differently. Pancreatic cancer generally diagnosed at a later stage since the symptoms are not easily detected or diagnosed. Factors such as chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity are some of the identified causes of pancreatic cancer. The pancreatic cancer therapy market growth is attributed to factors such as rise in number of patients suffering with pancreatic cancer, increasing healthcare expenditures for pancreatic drugs and increase in number of therapies launched in the market. Additionally, development of efficient therapy for pancreatic cancer treatment is expected to stimulate the market during the forecast period. However, side effects of the therapies and low success rate of treatments are expected to restrain the market of pancreatic cancer therapy.

For instance, the American Cancer Society suggests that pancreatic cancer accounts for approximately 3% of deaths of all cancers in the US. According to the National Institute of Health, an estimated of 68,615 patients in 2015 were living with pancreatic cancer in the US. The increasing incidence and prevalence of pancreatic cancer are expected to increase the demand for drugs, therapies, and treatment of patients. Moreover, the rising number of patients results in advancements in molecular biology and chemical drug formulation. Thus, a huge pool of patients who have pancreatic cancer is expected to increase the growth of the global pancreatic cancer therapy market over the forecast years.

Based on type, the pancreatic cancer therapy market is segmented into endocrine pancreatic cancer and exocrine pancreatic cancer. In 2017, the exocrine pancreatic cancer segment held the largest share of the market, by type. The exocrine pancreatic cancer segment is expected to grow at the fastest rate during the coming years as this type of cancer is the most common and majorly occurring type and thus is expected to have massive patient pool over the forecast years.

Based on therapy, the pancreatic cancer therapy market is segmented into biologic therapy, chemotherapy, and others. In 2017, biologic therapy segment held the largest share of the market, by therapy. Moreover, the biologic therapy segment is expected to grow at the fastest rate during the coming years owing to increasing number of novel upcoming immunotherapies as well as targeted cell therapy that treats the cancer without any severe side effects and has number of therapeutic benefits over the conventional chemotherapies.

Purchase Full Copy @ https://www.theinsightpartners.com/buy/TIPMD00002009/?openpr-10144

An outline of the regional analysis:
• Geographically, the report segments the Pancreatic Cancer Therapy market into North America, Europe, Asia-Pacific, Southeast Asia, Middle East and Africa, South America.
• Contribution of each region to the overall market share, along with their growth rate forecast are mentioned in the report.
• Total sales and revenue generated by each regional market are illustrated.
• Comprehensive assessment of all opportunities and risks in the Pancreatic Cancer Therapy market.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Pancreatic Cancer here

News-ID: 2163088 • Views:

More Releases from The Insight Partners

Electronic Design Automation Market Scope of The Report & Research Methodology
Electronic Design Automation Market Scope of The Report & Research Methodology
The electronic design automation market accounted to US$10.31 Bn in 2018 and is expected to grow at a CAGR of 12.0% during the forecast period 2019 - 2027, to account to US$28.27 Bn by 2027. Download PDF:- https://www.theinsightpartners.com/sample/TIPTE100001022?utm_source=Openpr&utm_medium=10413 Market leaders and key company profiles Agnisys Inc. Aldec, Inc. Autodesk, Inc. Cadence Design Systems, Inc. Labcenter Electronics Ltd. Keysight Technologies Mentor Graphics Corporation Silvaco, Inc. Synopsys, Inc. Contact Us : If you have any queries about this report or if you would like further
A New Era for Private Banking: Driven by Wealth and Technology
A New Era for Private Banking: Driven by Wealth and Technology
The global private banking market is poised for significant growth through 2031, according to a new report by The Insight Partners. The report, titled "Private Banking Market Share, Size, Trends, and Forecast by 2031," provides a detailed analysis of the industry's current landscape and future trajectory. It identifies the key drivers, challenges, and opportunities that will shape the market, offering valuable insights for businesses and stakeholders. The forecast predicts a
Printed Circuit Board (PCB) Market - Key Industry Dynamics
Printed Circuit Board (PCB) Market - Key Industry Dynamics
The report is categorized by Board Type (Rigid 1-2 Sided, Standard Multilayer, HDI, IC Substrate, Flexible Circuits) and further analyzes the market based on Component (Capacitors, Diodes, Integrated Circuits, Resistors). It also examines the market by End User Industry (Healthcare, Aerospace and Defense, Automotive, IT and Telecom, Consumer Electronics) . A comprehensive breakdown is provided at global, regional, and country levels for each of these key segments. Download PDF:- https://www.theinsightpartners.com/sample/TIPRE00016999?utm_source=Openpr&utm_medium=10413 Market leaders
Arterial Blood Collection Devices Market Growth Factors Driving 5.4% CAGR Globally
Arterial Blood Collection Devices Market Growth Factors Driving 5.4% CAGR Global …
Arterial Blood Collection Devices market forecast to 2031: 5.4% CAGR, growing usage of tubes, needles & safety systems, led by hospitals globally. The Arterial Blood Collection Devices market is moving into a steady growth phase, driven by a worldwide trend toward precision diagnostics, enhanced safety features, and the spread of hospital and clinic facilities at unprecedented rates. Technical in nature, the industry's impact is deeply human-safety for procedures, more rapid diagnosis,

All 5 Releases


More Releases for Pancreatic

Growing Pancreatic Cancer Cases : Pivotal Factor Influencing Pancreatic Cancer D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pancreatic Cancer Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pancreatic cancer drugs has seen consistent growth over the past few years. An escalation from $3.96 billion in 2024 to $4.1 billion in 2025 is projected, marking a compound annual
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Pancreatic Cancer Diagnostic Market Through 2025? The market size for pancreatic cancer diagnostics has been witnessing robust growth in recent times. There will be a growth from $4.24 billion in 2024 to $4.55 billion in 2025, showcasing a Compound Annual Growth Rate
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
The Pancreatic Cancer Diagnostic Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Pancreatic Cancer Diagnostic Market Size and Projected Growth Rate? There has been a significant expansion in the pancreatic cancer diagnostic market recently. This market is projected to increase from a value
Pancreatic Amylase Reagent Kits: Streamlining Enzyme Analysis for Efficient Panc …
Pancreatic Amylase Reagent Kits Market 2023 Forecast: Unveiling Opportunities and Growth Pancreatic Amylase Reagent Kits Market research report helps to recognize the market challenges and opportunities. Global Pancreatic Amylase Reagent Kits Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of
Pancreatic Cancer Treatment
Pancreatic Cancer Treatment Market describes its growth, size, share, Forecast and trends to 2025 Pancreatic Cancer Treatment Market Production and Demand Analysis 2019 to 2025 Pancreatic Cancer Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025 Pancreatic Cancer Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Pancreatic Market to Insight By 2025: Top Key Vendors Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to
Pancreatic Cancer Drug Pipeline Analysis
“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each